Nuon Therapeutics is a clinical stage biotechnology company developing medicines to treat autoimmune disease and pain.
The company's lead compound is the oral drug tranilast, which will be evaluated in clinical trials for Multiple Sclerosis and Rheumatoid Arthritis.
Nuon Therapeutics is committed to advancing novel therapies through clinical development in well designed, safe and cost effective trials.
